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The immunological mechanisms responsible for the recognition and rejection 
of allogeneic bone marrow transplants  have remained obscure for many years. 
While it was initially assumed that all transplanted  allogeneic tissues are elimi- 
nated by the same cell-mediated effector mechanisms,  it soon became apparent 
that  the  rejection  of bone  marrow  allografts  may  involve  different  cellular 
mechanisms  than  those  responsible  for  rejection  of skin  allografts.  The  key 
observation was that relatively small numbers of bone marrow cells transplanted 
into lethally irradiated  T  cell-deficient nude mice (1) or normal mice (2, 3) are 
rejected, whereas lethally irradiated  beige mice, which lack natural killer (NK) 1 
cell activity (4-8), fail to reject marrow grafts (6, 7).  This led to the hypothesis 
that  NK cells may be responsible for the rejection of relatively small grafts of 
allogeneic  or  semiallogeneic  bone  marrow  by  irradiated  recipients  (9).  This 
hypothesis obtained strong support from our recent demonstration that injection 
of cloned NK cells into NK-deficient mice restores the ability of these mice to 
reject  bone  marrow  allografts  (7,  10).  One  observation  presents  a  paradox, 
however:  NK  cells exhibit  no  H-2-specific target  cell  lysis  in  vitro  (1 1),  even 
though  bone  marrow  graft  rejection  in  vivo  is  exquisitely  H-2  specific.  The 
hemopoietic  histocompatibility  (Hh)  determinants  recognized  during  marrow 
graft rejection map primarily to the H-2D (12,  13) or H-2K regions (14) of the 
murine  major histocompatibility gene complex (MHC). Therefore,  if NK cells 
are in fact the mediators of bone marrow graft rejection in irradiated  mice, the 
mechanisms by which they perform this specific function must be elucidated. 
Here we report that the apparent paradox between the finding that NK cells 
are not H-2 specific in  vitro,  but cause H-2-specific marrow  graft rejection  in 
vivo, can be explained on the basis of the ability of NK cells to lyse targets in an 
antibody-dependent cell-mediated (ADCC)-type reaction. We show that there is 
a target-specific natural antibody in responder mice, which, in conjunction with 
NK cells, causes specific bone marrow graft rejection. 
This work was supported by grants CA 15581, CA 19334, and CA 37706 from the U. S. Public 
Health Service  and by grant IM-284 from the American Cancer Society. 
~  Abbreviations used in  this paper:  ADCC, antibody-dependent cell-mediated cytotoxicity; Hh, 
hemopoietic histocompatibility; MHC, major histocompatibility complex; NK, natural killer cells; 
PBS, phosphate-buffered  saline. 
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Materials and  Methods 
Mice.  The following mouse strains, all bred in our animal facility were used: C57BL/ 
6J,  C57BL/6  beige  (bg/bg),  C57BL/6  (bg/+),  BALB/c,  (C57BL/6  x  C3H)F~,  and 
(C57BL/6 x  C3H)F, (bg/bg). C3H/He, DBA/2, (C57BL/6 x  DBA/2)Fb 129/J, 129/ReJ, 
and 129/SvJ mouse strains and the original breeding pairs for C57BL/6 (bg/bg) and C3H 
(bg/bg)  mice were  purchased  from The Jackson  Laboratory (Bar  Harbor,  ME).  The 
recombinant strains  B10,  B10.D2,  B10.A(18)R,  and  D2.GD were purchased from the 
Scripps Clinic and Research Foundation Vivarium (La Jolla, CA). 
Cell Lines.  The isolation and characterization of NK cell clones have been described 
in detail elsewhere (11,  15,  16). For all studies, the C57BL/6 NK clones, NKB61A2 and 
NKB61B 10 were used. Both clones were propagated in conditioned media prepared from 
cell supernatants of concanavalin A-stimulated normal spleen cells (Con A SN) (11,  15, 
16).  The  following  tumor  cells,  propagated  in  vitro  in  Dulbecco's  minimal  essential 
medium supplemented with  10% horse serum were used as target cells for cytotoxicity 
assays: the C3H myeloma C 1.18.4 (H-2k), the BALB/c RAW 253 (H-2  d) (R. Hyman, Salk 
Institute, San Diego, CA), and the C57BL/6 thymic lymphoma EL4 (H-2b). 
Bone Marrow  Transplantation.  As bone marrow recipients, either normal mice, mice 
carrying the  bg/bg mutation  (i.e.,  NK-deficient) (4)  or mice treated with four weekly 
doses of 200 rad 3' irradiation (i.e.,  NK-deficient) were used (17).  Shortly before bone 
marrow cell transfer, recipient mice were exposed to a lethal dose (800-950 rad) of 6°Co 
3' irradiation. Bone marrow cells, obtained from the femur of respective donor mice, were 
injected intravenously into sex- and age-matched lethally irradiated recipients. Prolifera- 
tion of transplanted cells was assessed 5-12 d later by measuring the incorporation of ~sI- 
uridine into splenocyte DNA (2). The dose of bone marrow, 0.5-2 x  10  6 cells per mouse, 
was  adjusted  for  each  respective  donor-recipient  strain  combination  such  that  upon 
injection of ~I-uridine,  ~1% of the radioactivity was incorporated into the spleens of 
irradiated recipient mice that had been transplanted with syngeneic bone marrow. In each 
experiment, the value of incorporated radioactivity determined in this syngeneic growth 
control  was arbitrarily set  at  100  U  and  all  values in  the  experimental  groups  were 
normalized relative to this uninhibited bone marrow growth control. Irradiated mice not 
injected with marrow cells were used as negative controls for '~SI-uridine incorporation 
(~2 U). Animals with ~10 U  showed no visible spleen colonies, while animals with 50- 
100 U  had >200 spleen colonies. The mean and standard error of the arithmetic mean 
for each group of mice (three to six animals) are given. Groups of mice injected with 
syngeneic cloned NK cells received 2 x  108 cells intravenously 4-7 d before bone marrow 
transplantation.  All data presented are from experiments assayed on day 5 after bone 
marrow transplantation.  In some experiments, donor bone marrow cells (1-2 ×  106/ml) 
were incubated for 30 min at 4°C with mouse serum (1:5 vol/vol)before transplantation. 
Antibodies and Mouse Sera.  Individual mice of the respective strains were bled and 
their serum was collected 24 h before use in marrow transplant and ADCC experiments. 
Supernatants from hybridomas 1 I-4-1 (anti-H-2K  k, IgG2a) (18) and 34-5-8 (anti'H-2D  a, 
IgG2a) (19) were used as controls for the ADCC assays. 
Depletion of Serum Antibody  by Affinity  Chromatography.  Immunogiobulin (Ig) was re- 
moved from C57BL/6 mouse serum using a rabbit anti-mouse Ig agarose-coupled affinity 
column kindly provided by Dr.  I. Trowbridge, Salk Institute, San Diego, CA.  1 ml of 
mouse serum was loaded on to a  10-ml affinity column, and the column was incubated 
for 30 min at room temperature and then washed with 0.1  M phosphate-buffered saline 
(PBS), pH 7.0. Ig was eluted from the column with 1 M propionic acid, pH 3.0. Collected 
fractions were neutralized, dialyzed against PBS, filtered, and then assayed for activity in 
bone marrow transplants. 
Antibody-dependent  Cell-mediated and  Complement-mediated Cytotoxicity Assays.  ADCC 
activity was assessed using a standard 5~Cr release assay in microtiter plates. Monoclonai 
antibodies or mouse sera were titrated in microtiter plates, 5~Cr-labeled  targets (104/well) 
were added to various numbers of fresh C57BL/6 splenocytes or cloned C57BL/6 NK 
effector cells (effector/target ratios of 100:1,  50:1,  and 25:1), and the mixture (200 #1) 
was incubated at 37°C  in  5% CO~ between 4 and  10  h.  After incubation,  plates were WARNER  AND  DENNERT  565 
centrifuged (400 g),  100 #l of supernatant was removed, and released radioactivity  was 
determined in a gamma spectrometer. The percent cytotoxicity was calculated as follows: 
[(experimental  release -  spontaneous release)/(maximum  release -  spontaneous release)] 
x  100. Spontaneous (3%]h) and maximum release values were determined by incubation 
of ~]Cr-labeled targets without effector cells in the presence of medium plus antibody or 
serum and 1 M HCI, respectively.  ADCC assays were performed in RPMI 1640 medium 
supplemented  with  antibiotics  and  0.5%  bovine serum  albumin  (Calbiochem-Behring 
Corp., La Joila, CA). For assay of complement-mediated cytotoxicity,  a selected  rabbit 
serum with low toxicity to mouse cells was used at a final dilution  of 1:20. 
Results 
NK Cells Cause H-2-specific  Bone Marrow Graft Rejection  In Vivo.  The abilitv 
of lethally  irradiated  mice to reject allogeneic (2) or semiailogeneic (20) bone 
marrow  grafts of certain  H-2 specificities has been noted in  the past in  many 
different strain combinations. C57BL/6 (H-2  b) mice, for example, reject BALB/ 
c (H-2  -d) marrow grafts but fail to reject C3H (H-2  k) grafts, whereas certain  129 
strain  (H-2  ~:)  mice  reject  C3H,  but  not  BALB/c  marrow  transplants  (14). 
(C57BL/6 ×  C3H)F] and (C57BL/6 ×  BALB/c)FI hybrid mice reject C57BL/6 
parental bone marrow, but not C3H and BALB/c parental  grafts, respectively. 
In the majority of strain combinations, the specificity of this rejection is controlled 
by determinants encoded in or near the D region of the H-2 gene complex (12, 
14), an observation that can also be reproduced in NK-deficient C57BL/6 bg/ 
bg mice that are reconstituted with cloned NK cells (7). In Fig.  1, for example, 
it is shown that C57BL/6 bg/+ mice that are heterozygous for the bg allele and 
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FIGURE  1.  Genetic specificity of NK-mediated  bone marrow  allografi  rejection.  Lethally 
irradiated C57BL/6 recipient mice were transplanted with I ×  10  ° bone marrow cells obtained 
from H-2 recombinant donors possessing d alleles in various regions of the H-2 complex. NK- 
deficient C57BL/6 beige mice were given 2  x  106 NKB61A2 cloned NK cells 4-7 d  before 
marrow transplantation. Values represent marrow growth units ±  SE. 566 
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FIGURE 2.  Induction of bone marrow rejection by serum transfer from responder to non- 
responder mice. The respective irradiated recipient mice were transplanted with either 5 x 
10  ~ C3H or 1 x  10  e BALB/c donor bone marrow cells. In serum transfer experiments, bone 
marrow  cells were  mixed  with their  respective donor serum  pools before injection into 
irradiated nonresponder recipients. Values represent marrow growth units _+ SE. 
therefore  possess  normal  NK  activity  reject  B10.D2  (KdD  d)  grafts  and 
B10.A(18R)  (KbD  d)  grafts,  while  showing  much  weaker  rejection  of  D2.GD 
(KdD  b)  grafts.  In  contrast,  NK-deficient  C57BL/6  bg/bg  mice  do  not  reject 
marrow  grafts  unless they have been previously injected with cloned  NK cells, 
in  which  case  rejection  is  identical  to that  of bg/+  heterozygotes.  This  result 
demonstrates  that  cloned  NK  cells can  induce  marrow  graft  rejection  in  NK- 
deficient  mice  and  that  the  specificity  of  rejection  observed  in  these  strain 
combinations is identical to that of normal  mice. 
Ability of Mice to Reject Bone Marrow Allografts  Can Be Passively Transferred  by 
Serum from Responder  to Nonresponder  Mice.  Since  NK cells do not  show  H-2 
specificity  in  vitro  (11),  it  was  suspected  that  an  in  vivo  component,  such  as 
antibody, may convey specificity. To examine this possibility, we made use of the 
observation that particular  bone marrow allotypes grow only in one member of 
certain H-2-similar recipient mouse strains. For example, C3H marrow is rejected 
by certain  129 (H-2 b~) strains  but not by C57BL/6  (H-2  b) mice (14).  Similarly, 
BALB/c (H-2  a) marrow is rejected by C57BL/6 and CBA (H-2 k) but not by 129/ 
SvJ and  C3H  (H-2 k) mice  (12).  Therefore,  experiments  were designed  to  test 
whether  serum collected from responder  mice and injected  into  nonresponder 
mice is able to induce  marrow  graft rejection  in nonresponders.  In  Fig.  2, it is 
seen that C3H bone marrow  is not rejected by either  C57BL/6 or strain  129/J 
mice, but is rejected by strains  129/ReJ and 129]SvJ. Sera obtained from C57BL/ 
6 or 129/J mice and injected in conjunction with C3H marrow into nonresponder 
C57BL/6  recipients  has  little  effect on  donor  marrow  growth.  However,  sera 
from  129/ReJ  and  129]SvJ  cause  a  significant  suppression  of  C3H  marrow 
transplant  growth  in  C57BL]6  recipients.  In  an  analogous  system,  BALB/c 
marrow grafts are rejected by CBA but not by C3H mice. If the serum of either 
CBA or C3H is injected in conjunction  with BALB/c bone marrow into nonre- WARNER  AND  DENNERT 
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FIGURE 3.  Correlation  between the resistance of individual  129/ReJ mice to marrow grafts 
and  the  ability  of  their  serum  to  induce  graft  rejection  in  nonresponder  mice.  Irradiated 
recipient mice were transplanted with either 5  ×  10  ~ C3H donor bone marrow cells or bone 
marrow cells mixed with serum (1:5 vol/vol) from individual  129/ReJ mice. 
sponder  C3H  mice,  only  the  CBA  serum  transfer  results  in  a  suppression  of 
BALB/c marrow transplant growth. 
Variability in Individual  129/ReJ Mice to Reject a Bone Marrow Graft Is Reflected 
in the Potency of Their Sera to Transfer the Ability to Reject Bone Marrow AUografts 
to Nonresponder  Mice.  We  noted during the course of these experiments  that 
individual  129/ReJ  strain  mice exhibit some variation  in their ability to reject 
C3H bone marrow transplants.  It was therefore interesting to examine whether 
this variability correlates with the capacity of the serum from individual  129/ReJ 
strain  mice  to induce  marrow graft  rejection  in  nonresponder  mice.  129/ReJ 
mice  were  bled  and  individually  tested  for C3H  marrow graft  rejection,  and 
their serum was simultaneously tested for its capacity to cause C3H graft rejection 
in nonresponder C57BL/6  recipients.  The results in Fig. 3 show that there is a 
striking correlation between the ability of mice to reject C3H marrow grafts and 
their ability to confer this capacity via their serum to nonresponder mice. It was 
observed,  however,  that  serum-induced  graft  rejection  is  often  not  quite  as 
efficient asthe  direct  rejection  seen  in  the  responder  serum  donors  (Fig.  3), 
which may be explained by the relatively low amount of serum (i.e., 0.1-0.3  ml) 
injected into recipient mice. 
Bone  Marrow  Rejection  Induced  in  Nonresponder  Mice  by  Serum  Transfer  Is 
Specific.  Since rejection of H-2 a bone marrow by C57BL/6  mice is very strong 
(Fig. 1) and depends primarily on the expression of determinants of marrow cells 
encoded in the H-2D region, it was interesting to explore whether serum from 
C57BL/6  mice is also able to cause rejection of marrow expressing the D a allele 
in  nonresponder  recipients.  Fig.  4  shows  that  C57BL/6  recipient  mice  reject 
B 10.D2 (KdD a) and B 10.A(18R) (KbD  d) but not D2.GD (KaD  b) grafts. In contrast, 
marrow transplants  from  B10.D2  and  B10.A(18R)  are not rejected by nonre- 
sponder  strain  129/SvJ  mice (Fig.  4).  Transfer  of C57BL/6  serum along with 568  SPECIFIC  BONE  MARROW  REJECTION  BY  NATURAL  KILLER  CELLS 
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FIGURE 4.  Genetic  specificity of bone  marrow  graft  rejection  following serum  transfer. 
Serum  from  C57BL/6  responder  mice  was  mixed with  bone  marrow  obtained  from  H-2 
recombinant donor mice possessing d alleles in various regions of the H-2 complex. The sera 
(1:4 dilution) and donor bone marrow cell (1 x  10  e cells) mixtures were injected intravenously 
into irradiated nonresponder  129/SvJ recipient mice and marrow growth assayed after 5 d. 
Donor  marrow  without  serum  was  also  transplanted  into  C57BL/6  and  129/SvJ  control 
groups. Values represent marrow growth ±  SE. 
donor marrow cells into  129/SvJ recipients results in the rejection of B10.D2 
and B10.A(18R) marrow but not of D2.GD marrow (Fig. 4). These results show 
that  marrow  graft  rejection  is  not  only  induced  by  transfer  of serum  from 
responder to nonresponder mice, but, in addition, the rejection appears to be 
H-2D  a specific. 
Component Responsible for Induction  of Marrow Graft Rejection in Nonresponder 
Mice by Serum  Transfer  Adsorbs to  and  Can  Be Eluted from  an  Anti-lg A Oinity 
Column.  The finding that serum-induced marrow graft rejection in nonrespon- 
der mice is specific suggested that serum antibody is responsible for the graft 
rejection induced by serum transfer. If this were the case, then depletion of Ig 
from  responder  serum  should  eliminate  its  ability  to  induce  marrow  graft 
rejection in nonresponder mice. Accordingly, C57BL/6 serum was applied to a 
rabbit  anti-mouse  Ig agarose-coupled affinity column and  the absorbed  and 
nonadsorbed  materials  were  tested  for  their  ability  to  induce  marrow  graft 
rejection. The results (Table I) showed that both unfractionated C57BL/6 serum 
as well as eluted column-bound material (i.e., Ig) are able to induce rejection of 
BALB/c bone marrow in otherwise nonresponsive  129/SvJ  recipient mice. In 
contrast, the Ig-depleted C57BL/6  serum was unable to induce marrow graft 
rejection. These results strongly argue that the serum component responsible 
for marrow graft rejection is indeed antibody. 
Responder Serum May Induce Specific Target Cell Lysis in a Complement-mediated 
Cytolytic Reaction.  To further substantiate the conclusion that antibody is re- WARNER  AND  DENNERT  569 
TABLE  I 
Ig-depleted Responder Serum Does Not Induce Marrow Graft 
Rejection 
C57BL/6 serum given  Marrow growth*  Marrow recipient  to recipient* 
C57BL/6  None  7 + 2 
129/SvJ  None  100 4- 14 
129/SvJ  Normal  9 4- 3 
129/SvJ  Ig depleted  97 4- 9 
129/SvJ  Ig fraction  8 4- 1 
* BALB/c bone marrow cells were injected with either normal C57BL/6 
serum, C57BL/6 serum that was Ig depleted by affinity chromatography, 
or the lg fraction of C57BL/6  serum that was bound and eluted from 
an affinity column. 
* Irradiated recipient mice were transplanted  with 1 x  106 BALB/c (H- 
2 d) bone marrow cells and assayed 6 d later for marrow growth. 
TABLE II 
Correlation Between Graft Rejection and Serum plus 
Complement-mediated Lysis 
Graft recip-  Graft and  Graft 
ient and 
serum  target  re.jec- 
donor  uon  donor 
Percent target cell lysis* 
Serum dilution 
1:4  1:8  1:16  1:32 
C57BL/6  C57BL/6  --  1  I  1  1 
C57BL/6  DBA/2  +  22  32  28  1 
C57BL/6  C3H*  --  1  1  1  1 
* Target lysis was assayed with rabbit complement and splenocytes that 
had been incubated with 10 #g/ml bacterial lipopolysaccharide for 48 h 
before the assay. 
* Other experiments have shown lysis on C3H targets. 
sponsible for marrow graft rejection in responder mice, sera of such mice were 
assayed for their ability to lyse targets in a  complement-mediated reaction.  We 
found that sera from C57BL/6 mice caused lysis of DBA/2 splenocytes, but not 
of C57BL/6  or C3H splenocytes in the presence of complement, a  finding that 
correlates with the specificity of marrow graft rejection (Table II). In subsequent 
experiments,  however,  we  observed  that  C57BL/6  sera  may also  occasionally 
lyse C3H splenocytes. This finding was unexpected, since C3H bone marrow is 
not rejected  by C57BL/6  mice.  Results discussed  below provide a  likely expla- 
nation  in  that  not  all  antibody  isotypes  may  be  able  to  cause  marrow  graft 
rejection, even though they are able to effect complement-dependent cell lysis. 
Responder Serum Is Able to Induce a Specific ADCC Reaction In Vitro.  Since the 
ability of responder mice to reject marrow grafts can be transferred  via serum 
antibody to nonresponder mice, one would expect that responder serum would 
induce  a  specific  ADCC  reaction  in  vitro.  Individual  responder  129/SvJ  and 
nonresponder C57BL/6 strain mice were bled and tested for C3H (H-2  k) marrow 
graft rejection, and their sera were subsequently assayed in vitro for ADCC on 
an  H-2  k  tumor  target.  The  results  in  Fig.  5  show  that  there  is  an  absolute 57O 
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FIGURE 5,  Correlation between the rejection by individual mice of H-2  k marrow grafts and 
the ability of their serum to induce in vitro ADCC of an H-2  k tumor target. Lethally irradiated 
recipient mice were transplanted with 5  X  l0  s C3H bone marrow cells 24  h  after sera of 
individual mice were collected for ADCC assay.  ADCC was performed at an effector/target 
ceil ratio of 100:1  using C57BL[6 effector splenocytes and SlCr-labeled C 1.18.4 tumor target 
cells in an 8-h assay; the final serum dilution was 1:8. 
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correlation between the ability of individual 129/SvJ mice to reject C3H marrow 
grafts and the capacity of their serum to induce ADCC of C 1.18.4 (H-2  k) targets. 
Furthermore, the ADCC reaction is target specific (Fig.  6) in that cytolysis of 
C1.18.4  (H-2k),  but not RAW253  (H-2  a) or EL4 (H-2  b) targets, is induced by 
serum from 129/SvJ mice that reject H-2  k but not H-2  a or H-2  b marrow grafts. 
In contrast, serum from C57BL/6 mice, which reject H-2  d but not H-2 k or H-2  b 
marrow grafts, is able to induce ADCC of RAW253 targets, but not of C 1.18.4 
or El4 target (Fig. 6). Therefore, it is apparent that in responder mice there is 
a serum component, probably antibody, that induces specific ADCC with splen- 
ocytes from nonresponder mice. 
Is the Mechanism of Hybrid Resistance  to Parental Marrow Grafts Similar to the 
Mechanism of Bone Marrow Allograft Rejection?  In the experiments described so 
far, induction of marrow graft rejection in nonresponder mice was demonstrated 
in  allogeneic  marrow  graft  recipient  and  donor  combinations.  To  explore 
whether a  similar  mechanism  was  operating  in  the  phenomenon  of hybrid 
resistance,  Fl  hybrid  mice  carrying the  beige  mutation  were  tested  for  the 
rejection of parental marrow grafts. The results in Table III show that (C57BL/ 
6 × C3H)F1 mice reject parental C57BL/6 but not C3H marrow grafts. However, 
the presence of the homozygous beige mutation in F~ mice results in the growth 
of the C57BL/6 marrow graft. This result suggests that the rejection of parental 
marrow grafts involves the participation of NK cells. To explore next whether 
F1  hybrid  mice  possess  antibody  with  antiparental  specificity,  serum  from 
(C57BL/6 ×  DBA/2)F1 mice was collected because these mice show a reproduc- 
ible and strong rejection of C57BL/6 but not DBA/2 grafts. Consequently, sera 
of these mice should be able to induce rejection of C57BL/6  grafts in nonre- 25- 
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FIGURE 6.  Specificity of 129/SvJ strain  sera in the ADCC reaction.  C57BL/6 splenocytes 
were used as effector (effector/target ratio  100:1) and  C1.18.4,  RAW253,  and  EL4  51Cr- 
labeled tumor cells were targets in a 9-h cytolytic assay.  Respective mouse sera, and the 11-4- 
1 (anti-H-2K  k) and 34.5.8 (anti-H-2D  d) monoclonal antibodies were used at final dilutions of 
1:5,  1  : 10, and  1  : 10, respectively. 
TABLE  III 
Bone Marrow Graft Rejection by F~ Hybrid Recipients 
Bone mar-  Marrow 
Bone marrow recipient*  row donor  Serum  growth 
(C57BL/6 X C3H)F~  C3H  --  86 _  16 
(C57BL/6 x  C3H)F~  C57BL/6  --  3 ±  1 
(C57BL/6 × C3H)F~ bg/bg  C3H  --  101 +  10 
(C57BL/6 x  C3H)F1 bg/bg  C57BL/6  --  100 ±  4 
(C57BL/6 X DBA/2)FI  DBA/2  --  85 ±  10 
(C57BL/6 x  DBA/2)F,  C57BL/2  --  4 +  1 
C3H  C57BL/6  --  100 4- 12 
C3H  C57BL/6  (C57BL/6 x  DBA/2)F~ $  32 _  5 
* Recipients irradiated with 800 rad ~, irradiation. 
* Injected with serum (1:2) collected 24 h before transplantation with 1 ×  106 donor bone marrow 
cells. 
sponder  recipients.  Since  C3H  mice  fail  to  reject  C57BL/6  marrow  grafts, 
(C57BL/6  X  DBA/2)F]  serum  was  injected  with  C57BL/6  marrow  grafts  into 
C3H  recipients.  With  some  batches  of mice,  a  relatively  weak  rejection  (Table 
III) was observed,  while in other  experiments  the serum  had  no effect (data  not 572  SPECIFIC  BONE  MARROW  REJECTION  BY  NATURAL  KILLER  CELLS 
shown).  Therefore, in  contrast to  the allogeneic models,  a  consistent serum- 
mediated marrow graft rejection could not be demonstrated in the semiallogeneic 
system. 
Discussion 
In this  study, we have examined the hypothesis that  specific bone  marrow 
graft rejection involves an ADCC-type mechanism in which NK cells and specific 
natural antibody participate.  Several approaches were used to obtain evidence 
for this hypothesis. We searched for a  component in  the serum of responder 
mice, which, when transferred to nonresponder mice, is able to induce specific 
marrow graft rejection. We found that serum from responder mice confers on 
allogeneic nonresponder marrow recipients the ability to reject bone marrow 
allografts in an H-2-specific manner. We noted, however, that graft rejection 
induced as a result of serum transfer was not always as efficient as that observed 
in direct transplants into serum donor mice. A likely explanation for this is that 
the natural serum antibody is limited, as we could not detect activity in responder 
sera diluted beyond a dilution of 1:20 in ADCC assays. Also, any limitation of 
natural antibody would be compounded following serum transfer,  since only 
0.1-0.3  ml of serum was transferred to nonresponder recipients in any given 
experiment. Nonetheless, our experiments clearly show that a serum component 
is able to induce rejection of bone marrow grafts in  otherwise nonresponder 
recipients. We believe that antibody is responsible for this induced marrow graft 
rejection for several reasons. Serum from responder mice is able to induce ADCC 
of targets expressing the same H-2 antigens as the rejected marrow graft. By 
testing individual mice, we observed that there is an absolute correlation between 
marrow graft rejection in  responder mice and the capacity of their serum to 
induce specific in vitro ADCC. Furthermore, marrow graft rejection, after serum 
transfer,  mapped to  the  same H-2  region (i.e.,  predominantly H-2D)  as that 
observed in  normal C57BL/6  responder mice.  Moreover, the capacity of re- 
sponder sera to induce marrow graft rejection could be abrogated after removal 
of immunoglobulin by anti-lg affinity chromatography. 
There are some previous observations that would argue against the involve- 
ment of antibody in allogeneic bone marrow graft rejection. For example, it was 
reported  that  antibody  could  not  be  detected at  the  peak  of marrow  graft 
rejection and was not induced as a result of transplantation (2, 21, 22). Antibody 
induction, however, would not be expected in irradiated animals and the small 
amounts of preformed antibody (i.e., natural) might have been adsorbed by the 
transplanted tissue and thus would not be detectable at the time of transplant 
rejection. It may, therefore, be crucial to assay the serum of untreated responder 
mice for the presence of antibody, as was done in the present study. Transfer of 
such sera from responder mice into nonresponder mice had been attempted 
previously without demonstratable effects (2).  A  possible  explanation for this 
failure could be that sera were injected intraperitoneally and the bone marrow 
transplant intravenously, while in our experiments both serum and transplant 
were injected together intravenously into nonresponder recipients. It is conceiv- 
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graft  rejection  was  due  to  insufficient amounts of antibody transferred into 
nonresponder  mice  and  the  inability  to  detect  serum  antibody  was  due  to 
adsorption to the marrow transplant. 
Our conclusion that specific serum antibody is involved in acute NK-mediated 
marrow graft rejection, may only hold for allogeneic marrow graft rejection 
models. In FI hybrid mice, the ability to reject a parental marrow graft appears 
also to involve NK cells, but was not consistently reflected in the capacity of their 
serum to cause marrow graft rejection in allogeneic nonresponder recipients. 
Unfortunately, this result cannot be clearly interpreted.  Rejection of parental 
marrow grafts in F1 hybrid mice is weaker than rejection in the allosystems, and 
serum transfer even  in  the allosystems does not always result  in  as  strong a 
rejection as in the responder mice from which the serum was drawn. Also, we 
do not know the specificity of the putative antibody in the F1 hybrid mice, or in 
which other strains of mice (besides the parental, which is rejected) the respective 
antigen is expressed. Therefore, we do not know in which strains of mice the 
serum of these F1 hybrid mice should or should not be assayed. Moreover, it is 
not evident whether the antibody specificity is always the same or whether it may 
vary. We do know, however, that (C57BL/6 x  C3H)F1 mice immunized with an 
H-2  b Abelson tumor are able  to  produce anti-H-2KbD  b antibody (23),  which 
demonstrates that  F1  hybrid mice are indeed capable of producing antibodies 
with anti-parental specificity. There is also ample evidence that natural antibody 
of various specificities can be found in normal animals. For example, it is known 
that T  cell-deficient nude mice, which exhibit high levels of NK activity also 
possess natural antibody of various specificities (24) and thus one could explain 
why nude mice specifically reject marrow transplants (1). It has also been shown 
that sera of normal rats, rabbits and mice possess antibody specificities that are 
very similar to the specificity of NK cells (25, 26). 
Another  interesting  finding  is  that  natural  anti-tumor  serum  reactivity in 
BALB/c mice appears to correlate with their resistance to various tumors (27). 
Thus, antibody of the appropriate specificity appears to be present in animals 
that express natural resistance to bone marrow or tumor grafts in many instances. 
Therefore, while the evidence for the participation of antibody is persuasive in 
the allogeneic bone marrow transplantation  systems, we have to consider the 
possibility of other mechanisms in the semiallogeneic Fl antiparental response of 
other mechanisms. Since bone marrow cells express histocompatibility antigens, 
it is clear that they may be stimulators and targets for specific T  killer cells. This 
is  particularly  relevant  in  allogeneic  models  but  may also  be  an  important 
consideration in the phenomenon of hybrid resistance (28). In the present model, 
marrow graft rejection was assayed 5 d after recipients were lethally irradiated, 
which should preclude sensitization of T  cells during the period of assay. On the 
other hand,  no critical experiments have yet been done to examine whether 
there is  indeed no sensitization  of recipient T  cells to  the transplanted  bone 
marrow in irradiated recipients. 
Another important question is what the antibodies in responder mice recognize 
on the transplanted bone marrow cells and by what mechanism they induce graft 
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for the antibody or are they identical to common histocompatibility antigens, 
i.e., H-2 antigens and minor histocompatibility antigens? In a recent study (29), 
it was convincingly demonstrated that, besides H-2D- and H-2K-encoded deter- 
minants, H-2I-coded antigens may influence bone marrow graft rejection, which 
suggests that at  least some of the  Hh antigens are identical to  H-2  antigens. 
Consequently,  one  would  expect  that  at  least  in  some  instances  the  serum 
antibody in responder mice would be H-2. In this regard, we have demonstrated 
that the ability of a mouse to reject a particular marrow graft is reflected in the 
capacity of its serum to induce an H-2-specific ADCC reaction in vitro. We also 
used complement-mediated cytolysis of targets in an attempt to demonstrate the 
respective antibody specifications in responder serum. However, the results were 
variable, which can be explained by the hypothesis that the antibody induces an 
NK-dependent ADCC reaction in vivo. 
It is well established that ADCC of nucleated targets is predominantly caused 
by  NK  cells.  For  instance,  beige  mice, as  well as  humans with  the  Chediak- 
Higashi  syndrome, not only lack NK activity but are also deficient in  ADCC 
activity (30,  31).  The cloned NK cells recently described express Fc receptors 
(32; unpublished observations) and exhibit ADCC. Moreover, in single-cell assays 
of effector/target cell conjugates, it was observed that the same effector cell lyses 
both an NK-susceptible as well as an antibody-coated target (33).  It therefore 
seems plausible to assume that the serum contained antibody in responder mice 
targets  NK  cells  to  be  cytolytic and/or  cytostatic  for  the  transplanted  bone 
marrow. Since IgM  compared with  IgG is inefficient in  inducing ADCC (34; 
unpublished results),  it is easy to see why ADCC assays detect a  specificity in 
responder sera comparable to that in marrow graft rejection, which cannot be 
consistently demonstrated in the complement-mediated cytotoxic reaction. 
Our  demonstration  that  acute  bone  marrow  allograft  rejection  is  due  to 
antibody-directed NK cells provides the first in vivo demonstration of the long- 
known in vitro ADCC reaction. 
Summary 
There is conclusive evidence that acute bone marrow transplant rejection in 
lethally irradiated mice is caused by natural killer (NK) cells. The rejection of 
marrow aliografts is exquisitely specific and is controlled by antigenic determi- 
nants  encoded in  or  near the  H-2  gene complex.  The  specificity of in  vivo 
marrow graft rejection contrasts with the in vitro specificity pattern of NK cells 
in cytotoxicity assays.  We therefore examined how NK cells cause H-2-specific 
marrow graft rejection in vivo. Several experimental approaches are presented 
that suggest that natural antibody, present in responder strains of mice, specifi- 
cally directs NK cells in an antibody-depedent cytolytic and/or cytostatic reaction, 
resulting in marrow graft rejection. The following evidence for this mechanism 
is documented. The ability to reject a marrow graft can be passively transferred 
by serum from responder to ailogeneic nonresponder mice and the specificity of 
rejection can be mapped within the H-2 region. Serum-induced marrow graft 
rejection is abrogated following depletion of immunoglobulin, and the serum of 
responder mice is able to induce a specific antibody-dependent cytotoxic reaction 
in vitro. WARNER  AND  DENNERT  575 
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